The current 1SXP market cap is 0. The company's latest EPS is EUR and P/E is N/A.
Year End September 29 2024 | 2023 | 2024 |
---|---|---|
EUR (€) | EUR (€) | |
Total Revenue | 898.6M | 957.09M |
Operating Income | 190.81M | 204.28M |
Net Income | 151.84M | 149.69M |
Year End September 29 2024 | 2023 | 2024 |
---|---|---|
EUR (€) | EUR (€) | |
Total Assets | 1.23B | 1.44B |
Total Liabilities | 539.65M | 650M |
Total Equity | 692.18M | 792.27M |
Year End September 29 2024 | 2023 | 2024 |
---|---|---|
EUR (€) | EUR (€) | |
Operating | 181.65M | 225.33M |
Investing | -171.41M | -145.93M |
Financing | -11.4M | -78.16M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | 0.64% |
Shares Outstanding | 0 |
Average Volume (1 week) | 6.93k |
Average Volume (1 Month) | 7.78k |
52 Week Change | -35.57% |
52 Week High | 41.60 |
52 Week Low | 22.26 |
Spread (Intraday) | 0.38 (1.51%) |
Company Name | Schott Pharma AG & CO KGaA |
Address |
hattenbergstrasse 10 mainz 55122 |
Website | https://www.schott-pharma.com |
Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions